MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, BCRX has $514,158K in assets. $633,311K in debts. $89,736K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
206.23%
Quick Ratio
203.48%
Cash Ratio
45.77%
Debt to Asset Ratio
123.17%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Trade receivables
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Royalty financing obligations
    • Others

Balance Sheets
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Cash and cash equivalents
89,736 104,713 110,643 304,767
Restricted cash
201 210 1,804 1,472
Short-term investments
185,011 216,137 278,344 119,543
Trade receivables
106,818 79,069 56,950 50,599
Inventory, net
5,398 8,087 28,683 27,533
Prepaid expenses and other current assets
17,182 13,752 19,542 12,586
Total current assets
404,346 421,968 495,966 516,500
Long-term inventory, net
23,990 23,187 --
Property and equipment, net
8,783 7,777 7,910 8,617
Long-term investments
61,164 20,323 0 18,077
Right of use assets
10,203 12,008 --
Other assets
5,672 5,157 13,084 6,806
Total assets
514,158 490,420 516,960 550,000
Accounts payable
15,826 11,644 20,893 14,356
Accrued expenses
126,413 113,292 102,882 87,565
Deferred revenue
--0 1,224
Share-based liability
13,743 ---
Operating lease liabilities
317 937 1,058 2,369
Finance lease liabilities
1,312 1,835 1,590 -
Royalty financing obligations
38,455 32,676 23,565 -
Total current liabilities
196,066 160,384 149,988 105,514
Operating lease liabilities
8,571 7,924 8,390 5,804
Finance lease liabilities
1,441 2,124 2,845 -
Royalty financing obligations
427,233 481,053 508,034 501,655
Secured term loan
0 314,869 303,231 231,624
Total liabilities
633,311 966,354 --
Common stock, 0.01 par value shares authorized - 450,000 shares issued and outstanding 213,060 and 208,543 at december31, 2025 and 2024, respectively
2,131 2,085 2,058 1,879
Additional paid-in capital
1,384,857 1,291,100 1,222,236 1,158,118
Accumulated other comprehensive income
38 921 1,337 26
Accumulated deficit
-1,506,179 -1,770,040 -1,681,159 -1,454,620
Total stockholders deficit
-119,153 -475,934 -455,528 -294,597
Total liabilities and stockholders deficit
514,158 490,420 516,960 550,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$185,011K (-14.40%↓ Y/Y)Trade receivables$106,818K (35.09%↑ Y/Y)Cash and cashequivalents$89,736K (-14.30%↓ Y/Y)Prepaid expenses andother current assets$17,182K (24.94%↑ Y/Y)Inventory, net$5,398K (-33.25%↓ Y/Y)Restricted cash$201K (-4.29%↓ Y/Y)Total current assets$404,346K (-4.18%↓ Y/Y)Long-term investments$61,164K (200.96%↑ Y/Y)Long-term inventory, net$23,990K (3.46%↑ Y/Y)Right of use assets$10,203K (-15.03%↓ Y/Y)Property and equipment,net$8,783K (12.94%↑ Y/Y)Other assets$5,672K (9.99%↑ Y/Y)Total assets$514,158K (4.84%↑ Y/Y)Accumulated deficit-$1,506,179K (14.91%↑ Y/Y)Total liabilities andstockholders deficit$514,158K (4.84%↑ Y/Y)Total stockholdersdeficit-$119,153K (74.96%↑ Y/Y)Additional paid-in capital$1,384,857K (7.26%↑ Y/Y)Common stock, 0.01 parvalue shares...$2,131K (2.21%↑ Y/Y)Accumulated othercomprehensive income$38K (-95.87%↓ Y/Y)Total liabilities$633,311K (-34.46%↓ Y/Y)Royalty financingobligations$427,233K (-11.19%↓ Y/Y)Total currentliabilities$196,066K (22.25%↑ Y/Y)Operating leaseliabilities$8,571K (8.17%↑ Y/Y)Finance leaseliabilities$1,441K (-32.16%↓ Y/Y)Accrued expenses$126,413K (11.58%↑ Y/Y)Royalty financingobligations$38,455K (17.69%↑ Y/Y)Accounts payable$15,826K (35.92%↑ Y/Y)Share-based liability$13,743K Finance leaseliabilities$1,312K (-28.50%↓ Y/Y)Operating leaseliabilities$317K (-66.17%↓ Y/Y)

BIOCRYST PHARMACEUTICALS INC (BCRX)

BIOCRYST PHARMACEUTICALS INC (BCRX)